These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20846150)

  • 1. New thoughts on the initiation of mucositis.
    Sonis ST
    Oral Dis; 2010 Oct; 16(7):597-600. PubMed ID: 20846150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current approaches in prevention and therapy of chemo- and radiotherapy-induced oral mucositis].
    Rosenthal C; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):53-65. PubMed ID: 11789420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of oral mucositis induced by chemotherapy and radiotherapy: an update.
    Vélez I; Tamara LA; Mintz S
    Quintessence Int; 2004 Feb; 35(2):129-36. PubMed ID: 15000636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence based care in the prevention and treatment of mucositis induced by chemo- and radiotherapy].
    Salgarello MC
    Assist Inferm Ric; 2003; 22(2):95-106. PubMed ID: 13677166
    [No Abstract]   [Full Text] [Related]  

  • 7. New understanding of oral mucositis should lead to targeted drugs.
    J Support Oncol; 2006 Feb; 4(2):80. PubMed ID: 16499127
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
    Sonis ST; Elting LS; Keefe D; Peterson DE; Schubert M; Hauer-Jensen M; Bekele BN; Raber-Durlacher J; Donnelly JP; Rubenstein EB; ;
    Cancer; 2004 May; 100(9 Suppl):1995-2025. PubMed ID: 15108222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regimen-related gastrointestinal toxicities in cancer patients.
    Sonis ST
    Curr Opin Support Palliat Care; 2010 Mar; 4(1):26-30. PubMed ID: 20040879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucositis: current management and investigations.
    Garden AS
    Semin Radiat Oncol; 2003 Jul; 13(3):267-73. PubMed ID: 12903015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising new approaches to managing mucositis.
    J Support Oncol; 2003; 1(4):245, 278. PubMed ID: 15334866
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research.
    Jensen SB; Peterson DE
    J Oral Pathol Med; 2014 Feb; 43(2):81-90. PubMed ID: 24261541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucositis--a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment].
    Piatkowska-Jakubas B; Darczuk D; Chomyszyn-Gajewska M; Skotnicki AB
    Przegl Lek; 2003; 60(12):815-20. PubMed ID: 15058023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of Tantum Verde in prevention and treatment of oral cavity mucosal damages after cytostatic and radiotherapy in cancer patients].
    Vopr Onkol; 2004; 50(5):618-22. PubMed ID: 15715110
    [No Abstract]   [Full Text] [Related]  

  • 15. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.
    Iglesias-Bartolome R; Patel V; Cotrim A; Leelahavanichkul K; Molinolo AA; Mitchell JB; Gutkind JS
    Cell Stem Cell; 2012 Sep; 11(3):401-14. PubMed ID: 22958932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod.
    Zamora R; Grishin A; Wong C; Boyle P; Wang J; Hackam D; Upperman JS; Tracey KJ; Ford HR
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G643-52. PubMed ID: 15947118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of oral mucositis correlates with the response of oral cancer to preoperative radiochemotherapy.
    Ikebe T; Seki K; Nakamura S; Takenoshita Y; Nakayama H; Shinohara M; Shirasuna K
    Int J Oral Maxillofac Surg; 2005 Sep; 34(6):642-5. PubMed ID: 15869866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucositis in cancer therapy.
    Sonis ST
    J Support Oncol; 2004; 2(6 Suppl 3):3-8. PubMed ID: 15605918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucositis: biology and management.
    Treister N; Sonis S
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):123-9. PubMed ID: 17413415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review.
    López-Castaño F; Oñate-Sánchez RE; Roldán-Chicano R; Cabrerizo-Merino MC
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):412-21. PubMed ID: 16264377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.